EVENT
Gene Therapy Development 2024
13-14 June 2024 | London, UK
Connect with our experts
Find our experts in booth 10, ready to discuss PCR based bioanalysis strategies for:
• Biodistribution
• Shedding
• Messenger RNA quantification
• Vector integrity
• Cytokine immuno profiling
Kennet Mattson
kennet.mattsson@tataa.com
SVP Commercial Operations • Business Development Manager
Jose Martins
jose.martins@tataa.com
Business Development Manager
Event contact form
"*" indicates required fields
why work with tataa?
The Power of Our Approach
Committed to quality, innovation, and fostering strong client relationships, we serve as your trusted partner to accelerate drug development. As a contract research organization, our mission is to push the boundaries of science and technology to generate accurate and reproducible data that shortens time-to-market.
All the required expertise
We are ahead of industry trends and always updated on the regulatory landscape and requirements for gene editing and nucleic acid-based therapies. Our purpose is providing data that’s easily auditable.
Total project transparency
We maintain transparency and proactively communicate throughout the project, ensuring our clients stay updated on the progress at all times. Transparency forms the cornerstone of our proven client model.
Confidence in your data
We use the highest quality reagents, adhere to dedicated controls, standardize and harmonize all processes per technical requirements like the MIQE guidelines. We deliver rapid, robust and reproducible results that are submission-ready.
Flexible and scalable
Every project is customized to meet our client’s specific needs. We manage projects of all sizes, including any or all phases from sample extraction to analysis and data transfer. Your goals are our deliverables.
